Last reviewed · How we verify
Indocyanine Green Retention test
At a glance
| Generic name | Indocyanine Green Retention test |
|---|---|
| Also known as | ICG test |
| Sponsor | VA Connecticut Healthcare System |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve (PHASE2)
- Prognostic Role of HVPG and ICG-R15 in the Short- and Medium-term Results of the Surgery of HCC on Cirrhosis
- Dynamic Liver Tests in Liver Disease
- Clinical Study of Indocyanine Green Displaying Pelvic Nerve in Radical Operation of Cervical Cancer (EARLY_PHASE1)
- Surrogate Markers of Portal Pressure (NA)
- Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma
- Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Indocyanine Green Retention test CI brief — competitive landscape report
- Indocyanine Green Retention test updates RSS · CI watch RSS
- VA Connecticut Healthcare System portfolio CI